Wealthspire Advisors (Maryland)’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,320
Closed -$253K 536
2020
Q2
$253K Buy
+1,320
New +$216K 0.02% 372
2019
Q2
Sell
-532
Closed -$55K 1675
2019
Q1
$55K Buy
532
+25
+5% +$2.58K ﹤0.01% 863
2018
Q4
$58K Buy
507
+51
+11% +$5.46K 0.01% 799
2018
Q3
$53K Buy
456
+24
+6% +$2.63K ﹤0.01% 942
2018
Q2
$45K Buy
432
+20
+5% +$2.02K ﹤0.01% 1015
2018
Q1
$41K Buy
412
+20
+5% +$1.89K ﹤0.01% 1063
2017
Q4
$33K Buy
392
+170
+77% +$14K ﹤0.01% 1160
2017
Q3
$17K Sell
222
-34
-13% -$2.6K ﹤0.01% 1360
2017
Q2
$20K Buy
256
+98
+62% +$7.01K ﹤0.01% 1272
2017
Q1
$11K Buy
158
+7
+5% +$484 ﹤0.01% 1313
2016
Q4
$9K Buy
151
+106
+236% +$6.49K ﹤0.01% 1261
2016
Q3
$3K Hold
45
﹤0.01% 1490
2016
Q2
$3K Hold
45
﹤0.01% 1448
2016
Q1
$3K Hold
45
﹤0.01% 1466
2015
Q4
$2K Buy
+45
New +$2.54K ﹤0.01% 1534

Other funds holding RMD

Wealthspire Advisors (Maryland)'s RMD Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) sold out of ResMed (RMD) in Q3 2020, closing a stake of 1,320 shares — an estimated $253K sold.

Wealthspire Advisors (Maryland) first reported a position in RMD in Q4 2015 and held it in 15 quarters. The position peaked at $253K in Q2 2020. 626 funds tracked by Wall St. Rank hold RMD as of Q3 2020.

  • Wealthspire Advisors (Maryland) reported no remaining ResMed position as of Q3 2020 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 1,320 ResMed shares in Q3 2020, an estimated $253K.
  • Wealthspire Advisors (Maryland) first reported a position in ResMed in Q4 2015 and held it in 15 quarters.
  • Wealthspire Advisors (Maryland)'s ResMed position peaked at $253K in Q2 2020.
  • 626 funds tracked by Wall St. Rank held ResMed as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.